摘要
目的：观察痰热清注射液治疗急性上呼吸道感染的临床疗效。方法：采取随机对照试验,选取急性上呼吸道感染患者60例,随机将其分为观察组和对照组,每组各30例。观察组用痰热清注射液每次20 mL加入5%葡萄糖注射液250 mL,静脉注射,1次/d;对照组用利巴韦林注射液0.5 g/次,加入5%葡萄糖注射液250 mL,静脉注射,1次/d。2组疗程均为5~7 d。结果：观察组总有效率96.7%,对照组总有效率83.3%,2组比较有显著性差异（P〈0.05）。结论：痰热清治疗急性上呼吸道感染疗效较好,且未发现明显毒副作用。
Objective：To observe clinical efficacy of Tanreqing injection in treatment of acute upper respiratory tract infection.Methods：60 patients of the acute upper respiratory infection were chosen to divided randomly into two groups with 30 patients in each group： the treatment group and the control group.The treatment group was treated with Tanreqing injection of 20 mL in 5% glucose injection 250 mL,intravenous injection,1 time/d.While,control group with Ribavirin Injection 0.5 g in 5% glucose injection 250 mL,intravenous injection,1 time/d.Both of the two group were treated for 5 to 7days.Results：The total effective rate was 96.7% in the treatment group;the total effective rate was 83.3% in the control group.There was difference statistically（P0.05）.Conclusion：The clinical efficacy of the Tanreqing in treatment of the acute upper respiratory tract infection are significantly better than the control group,and no obvious toxic and side-effects.
出处
《现代临床医学》
2011年第4期258-259,共2页
Journal of Modern Clinical Medicine
关键词
急性上呼吸道感染
痰热清注射液
疗效观察
acute upper respiratory tract infection
Tanreqing injection
observation of curative effect
